A little more than five years ago, a shiny white Falcon 9 rocket made its debut flight, boosting a Cargo Dragon spacecraft to the International Space Station. Over the next year, it would launch a ...
Forbes contributors publish independent expert analyses and insights. I write about biodiversity and the hidden quirks of the natural world. This voice experience is generated by AI. Learn more. This ...
This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. A SpaceX Falcon Heavy rocket carrying the National Oceanic and Atmospheric Administration's ...
Falcon Cam at a Manhattan office building revealed the first peregrine falcon to hatch there in years. By James Barron Good morning. It’s Thursday. Today we’ll find out about a newborn in a closely ...
Bristol Myers Squibb is securing an opportunity to compete in the next generation of cell therapies through the $1.5 billion acquisition of Orbital Therapeutics, a startup with a lead program nearing ...
Follow this author to personalize your feed and get instant alerts. WHY FOLLOW? Custom Feed: See the stories that matter most to you. Smart Alerts: Get notified about major news as it happens. Update ...
Learn how to design and craft your own custom laser-cut sign using the Creality Falcon A1. This step-by-step laser tutorial will guide you through the entire process, from setup to the perfect ...
(L-R) Willy Falcon and Ozzie Areu Courtesy A.R.E.U. EXCLUSIVE: Cuban-American drug kingpin Willy Falcon is finally poised to tell the story of how he built the billion-dollar cocaine empire Los ...
Sigvotatug vedotin (SV), an investigational integrin beta-6 (IB6)–directed antibody‒drug conjugate (ADC), and pembrolizumab combination therapy: Initial results from an ongoing phase 1 study ...
Bristol Myers Squibb, Board Chair of BMS and CEO Christopher Boerner, PhD, have committed the pharma giant to investing $40 billion over the next five years toward U.S. research and development (R&D), ...
Roughly two years after securing a former Novartis facility in Illinois to support its CAR-T cancer treatments Breyanzi and Abecma, Bristol Myers Squibb is rethinking its operations at the site. BMS ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results